Concepedia

Konrad J. Mostert

KJ

Statistics

Publications

5

Citations

235

H-Index

5

Active since

2018

Affiliations

Stellenbosch University(Current)

University of Groningen

Centrale Marseille

Centre d’Immunologie de Marseille-Luminy

Harvard University

Konrad J. Mostert is an author at Stellenbosch University specializing in coenzyme a biosynthesis, enzyme inhibition, and medicinal chemistry.

ORCID

Publications per year

2018–2024

5

Publications

5

AI is a viable alternative to high throughput screening: a 318-target study

Izhar Wallach, Denzil Bernard, Kong T. Nguyen et al. · Scientific Reports · 2024 · 120 citations · Full text

, , +16

Harnessing the Vnn1 pantetheinase pathway boosts short chain fatty acids production and mucosal protection in colitis

Virginie Millet, Thomas Gensollen, Michael Maltese et al. · Gut · 2022 · 38 citations · Full text

, , +17

Vnn1 pantetheinase limits the Warburg effect and sarcoma growth by rescuing mitochondrial activity

Caroline Giessner, Virginie Millet, Konrad J. Mostert et al. · Life Science Alliance · 2018 · 32 citations · Full text

, , +17

Developing Pantetheinase-Resistant Pantothenamide Antibacterials: Structural Modification Impacts on PanK Interaction and Mode of Action

Leanne Barnard, Konrad J. Mostert, Willem A. L. van Otterlo et al. · ACS Infectious Diseases · 2018 · 27 citations

, , +14

The Coenzyme A Level Modulator Hopantenate (HoPan) Inhibits Phosphopantotenoylcysteine Synthetase Activity

Konrad J. Mostert, Nandini Sharma, Marianne van der Zwaag et al. · ACS Chemical Biology · 2021 · 18 citations · Full text

, , +15

1–5 of 5